Загрузка...
Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
Tyrosine kinase inhibitor treatment of chronic myeloid leukemia (CML) has demonstrated beneficial effects. However, resistance to tyrosine kinase inhibitors and disease relapse are still a challenge for CML therapy. In this study, we analyzed bone marrow samples from 149 CML patients and 15 control...
Сохранить в:
| Опубликовано в: : | Cell Death Dis |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6113287/ https://ncbi.nlm.nih.gov/pubmed/30154435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0900-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|